During the past decade, Piedmont HealthCare, d/b/a Carolinas Center for Liver Disease conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Piedmont HealthCare, d/b/a Carolinas Center for Liver Disease" are "Nonalcoholic Steatohepatitis" (2 trials). Many other conditions were trialed in "Piedmont HealthCare, d/b/a Carolinas Center for Liver Disease" in a lesser frequency.

Most popular intervention types in "Piedmont HealthCare, d/b/a Carolinas Center for Liver Disease" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo to match SEL 18 mg" (2 trials), "Placebo to match SEL 6 mg" (2 trials) and "SEL" (2 trials). Other intervention names were less common.

The vast majority of trials in "Piedmont HealthCare, d/b/a Carolinas Center for Liver Disease" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Piedmont HealthCare, d/b/a Carolinas Center for Liver Disease". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Piedmont HealthCare, d/b/a Carolinas Center for Liver Disease, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Piedmont HealthCare, d/b/a Carolinas Center for Liver Disease, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".